D. Baumgart and W. Sandborn, Inflammatory bowel disease: clinical aspects and established and evolving therapies, The Lancet, vol.369, issue.9573, pp.1641-1657, 2007.
DOI : 10.1016/S0140-6736(07)60751-X

D. Baumgart and S. Carding, Inflammatory bowel disease: cause and immunobiology, The Lancet, vol.369, issue.9573, pp.1627-1640, 2007.
DOI : 10.1016/S0140-6736(07)60750-8

B. Hayee, F. Rahman, G. Sewell, A. Smith, and A. Segal, Crohn???s disease as an immunodeficiency, Expert Review of Clinical Immunology, vol.6, issue.4, pp.585-596, 2010.
DOI : 10.1586/eci.10.32

A. Smith, F. Rahman, B. Hayee, S. Graham, D. Marks et al., Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease, The Journal of Experimental Medicine, vol.35, issue.9, pp.1883-1897, 2009.
DOI : 10.1038/nature06005

L. Cheng, B. Kanwar, H. Tcheurekdjian, J. Grenert, M. Muskat et al., Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome, Clinical Immunology, vol.132, issue.1, pp.124-131, 2009.
DOI : 10.1016/j.clim.2009.03.514

S. Pachlopnik, D. Canioni, D. Moshous, F. Touzot, N. Mahlaoui et al., Clinical similarities and differences of patients with http, pp.1522-1529, 2011.

H. Van-der-vliet and E. Nieuwenhuis, IPEX as a Result of Mutations in FOXP3, Clinical and Developmental Immunology, vol.177, issue.5, p.89017, 2007.
DOI : 10.1172/JCI25947

B. Begue, J. Verdier, F. Rieux-laucat, O. Goulet, A. Morali et al., Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel Disease, The American Journal of Gastroenterology, vol.29, issue.8, pp.1544-1555, 2011.
DOI : 10.1038/ajg.2011.112

E. Glocker, D. Kotlarz, K. Boztug, E. Gertz, A. Schaffer et al., Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor, New England Journal of Medicine, vol.361, issue.21, pp.2033-2045, 2009.
DOI : 10.1056/NEJMoa0907206

E. Glocker, N. Frede, M. Perro, N. Sebire, M. Elawad et al., Infant colitis???it's in the genes, The Lancet, vol.376, issue.9748, p.1272, 2010.
DOI : 10.1016/S0140-6736(10)61008-2

M. De-waal, J. Abrams, B. Bennett, C. Figdor, and J. De-vries, Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, pp.1209-1220, 1991.

L. Williams, G. Ricchetti, U. Sarma, T. Smallie, and B. Foxwell, Interleukin-10 suppression of myeloid cell activation - a continuing puzzle, Immunology, vol.76, issue.3, pp.281-292, 2004.
DOI : 10.1038/nm0302-240

O. Broberger and P. Perlmann, AUTOANTIBODIES IN HUMAN ULCERATIVE COLITIS, Journal of Experimental Medicine, vol.110, issue.5, pp.657-674, 1959.
DOI : 10.1084/jem.110.5.657

K. Das, A. Dasgupta, A. Mandal, and X. Geng, Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis, J Immunol, vol.150, pp.2487-2493, 1993.

B. Lundgren, F. Rorsman, G. Portela-gomes, L. Grimelius, K. Ekdahl et al., Identification of complement C3 as an autoantigen in inflammatory bowel disease, European Journal of Gastroenterology & Hepatology, vol.22, issue.4, pp.429-436, 2010.
DOI : 10.1097/MEG.0b013e32833283b1

A. Rahbar, L. Bostrom, and C. Soderberg-naucler, Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease, Journal of Autoimmunity, vol.26, issue.3, pp.155-164, 2006.
DOI : 10.1016/j.jaut.2006.02.003

D. Roggenbuck, G. Hausdorf, L. Martinez-gamboa, D. Reinhold, T. Buttner et al., Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease, Gut, vol.58, issue.12, pp.1620-1628, 2009.
DOI : 10.1136/gut.2008.162495

E. Ebert, A. Panja, K. Das, R. Praveen, X. Geng et al., Patients with inflammatory bowel disease may have a transforming growth factor-??-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies, Clinical & Experimental Immunology, vol.153, issue.1, pp.65-71, 2009.
DOI : 10.1111/j.1365-2249.2008.03802.x

R. De-lemos, P. Galle, M. Svenson, B. Pedersen, and M. Hansen, Preparation and validation of radio iodinated recombinant human IL-10 for the measurement of natural human antibodies against IL-10, Journal of Immunological Methods, vol.350, issue.1-2, pp.46-53, 2009.
DOI : 10.1016/j.jim.2009.07.005

R. De-lemos, P. Galle, B. Pedersen, and M. Hansen, A state of acquired IL-10 deficiency in 0.4% of Danish blood donors, Cytokine, vol.51, issue.3, pp.286-293, 2010.
DOI : 10.1016/j.cyto.2010.06.009

M. Watanabe, K. Uchida, K. Nakagaki, H. Kanazawa, B. Trapnell et al., Anti-cytokine autoantibodies are ubiquitous in healthy individuals, FEBS Letters, vol.28, issue.10, pp.2017-2021, 2007.
DOI : 10.1016/j.febslet.2007.04.029

R. Doffinger, M. Helbert, G. Barcenas-morales, K. Yang, S. Dupuis et al., Autoantibodies to Interferon????? in a Patient with Selective Susceptibility to Mycobacterial Infection and Organ???Specific Autoimmunity, Clinical Infectious Diseases, vol.38, issue.1, pp.10-14, 2004.
DOI : 10.1086/380453

K. Kisand, B. Wolff, A. Podkrajsek, K. Tserel, L. Link et al., Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines, The Journal of Experimental Medicine, vol.350, issue.2, pp.299-308, 2010.
DOI : 10.1002/eji.200535503

G. Holdstock, W. Ershler, and E. Krawitt, Defective lymphocyte IgA production in inflammatory bowel disease, Clinical Immunology and Immunopathology, vol.24, issue.1, pp.47-54, 1982.
DOI : 10.1016/0090-1229(82)90087-3

C. Anderson, G. Boucher, C. Lees, A. Franke, D. Amato et al., Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nature Genetics, vol.38, issue.3, pp.246-252, 2011.
DOI : 10.1046/j.1365-2036.2001.00981.x

J. Van-limbergen, D. Wilson, and J. Satsangi, The Genetics of Crohn's Disease, Annual Review of Genomics and Human Genetics, vol.10, issue.1, pp.89-116, 2009.
DOI : 10.1146/annurev-genom-082908-150013

E. Stange, S. Travis, S. Vermeire, W. Reinisch, K. Geboes et al., European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.2, issue.1, pp.1-23, 2008.
DOI : 10.1016/j.crohns.2007.11.001

G. Van-assche, A. Dignass, J. Panes, L. Beaugerie, J. Karagiannis et al., The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.4, issue.1, pp.7-27, 2010.
DOI : 10.1016/j.crohns.2009.12.003

I. Working, Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis?the Porto criteria, J Pediatr Gastroenterol Nutr, vol.41, pp.1-7, 2005.

A. Levine, A. Griffiths, J. Markowitz, D. Wilson, D. Turner et al., Pediatric modification of the Montreal classification for inflammatory bowel disease, Inflammatory Bowel Diseases, vol.17, issue.6, pp.1314-1321, 2011.
DOI : 10.1002/ibd.21493